D-0685-2021 Class I Ongoing

Recalled by Nuri Trading LLC — Fort Lee, NJ

FDA drug recall D-0685-2021 was initiated by Nuri Trading LLC on Mar 29, 2021 and is designated Class I. Reason for recall: Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making them unapproved drugs for which the safety and efficacy have… The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Jul 28, 2021
Initiation Date
Mar 29, 2021
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Shogun-X 7000 capsule, packaged in a) 1-count blister card and b) 10-count box, Nuri Trading LLC

Reason for recall

Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Distribution pattern

USA Nationwide

Code information

all lots within expiry

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0685-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0685-2021. Report a data issue: hello@regdatalab.com.